288 related articles for article (PubMed ID: 25418900)
81. Renal cell carcinoma in kidney allografts: histologic types, including biphasic papillary carcinoma.
Troxell ML; Higgins JP
Hum Pathol; 2016 Nov; 57():28-36. PubMed ID: 27396934
[TBL] [Abstract][Full Text] [Related]
82. [Tumors of the kidneys: new entities].
Compérat EV; Vasiliu V; Ferlicot S; Camparo P; Sibony M; Vieillefond A
Ann Pathol; 2005 Apr; 25(2):117-33. PubMed ID: 16142163
[TBL] [Abstract][Full Text] [Related]
83. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.
Moch H; Gasser T; Amin MB; Torhorst J; Sauter G; Mihatsch MJ
Cancer; 2000 Aug; 89(3):604-14. PubMed ID: 10931460
[TBL] [Abstract][Full Text] [Related]
84. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
85. [Leiomyomatous renal cell carcinoma : Controversy around a new entity].
Rausch S; Scharpf M; Moch H; Stenzl A; Bedke J
Urologe A; 2016 Mar; 55(3):376-80. PubMed ID: 26556266
[TBL] [Abstract][Full Text] [Related]
86. Ancillary studies in fine needle aspiration of the kidney.
Renshaw AA; Gould EW
Cancer Cytopathol; 2018 Aug; 126 Suppl 8():711-723. PubMed ID: 30156770
[TBL] [Abstract][Full Text] [Related]
87. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
88. WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade.
Browning L; Colling R; Verrill C
Diagn Pathol; 2021 Aug; 16(1):75. PubMed ID: 34419085
[TBL] [Abstract][Full Text] [Related]
89. [WHO classification 2004: tumors of the kidneys].
Compérat E; Camparo P; Vieillefond A
J Radiol; 2006 Sep; 87(9):1015-24. PubMed ID: 16936625
[TBL] [Abstract][Full Text] [Related]
90. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.
Yakirevich E; Ali SM; Mega A; McMahon C; Brodsky AS; Ross JS; Allen J; Elvin JA; Safran H; Resnick MB
Am J Surg Pathol; 2015 Jun; 39(6):858-63. PubMed ID: 25724004
[TBL] [Abstract][Full Text] [Related]
91.
Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
[TBL] [Abstract][Full Text] [Related]
92. Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features.
Mai KT; Kohler DM; Roustan Delatour NL; Veinot JP
Pathol Res Pract; 2006; 202(12):863-8. PubMed ID: 17034957
[TBL] [Abstract][Full Text] [Related]
93. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
94. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
95. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma.
Renshaw AA; Lee KR; Madge R; Granter SR
Acta Cytol; 1997; 41(4):987-94. PubMed ID: 9250289
[TBL] [Abstract][Full Text] [Related]
96. Renal FNA-based typing of renal masses remains a useful adjunctive modality: evaluation of 31 renal masses with correlative histology.
Masoom S; Venkataraman G; Jensen J; Flanigan RC; Wojcik EM
Cytopathology; 2009 Feb; 20(1):50-5. PubMed ID: 18476991
[TBL] [Abstract][Full Text] [Related]
97. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.
Delahunt B; Bethwaite PB; Nacey JN
Pathology; 2007 Oct; 39(5):459-65. PubMed ID: 17886093
[TBL] [Abstract][Full Text] [Related]
98. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
99. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
100. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
